60492-0173Level 3
CNJ-016 (Vaccinia Immune Globulin Intravenous (Human))
**Product type:** Human Prescription Drug
**Active ingredient:** HUMAN VACCINIA VIRUS IMMUNE GLOBULIN
**Strength:** 1 [iU]/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Emergent BioSolutions Canada Inc.
**Marketing category:** BLA (BLA125109)
**Pharmacologic class:** Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]
GET
/api/v1/systems/ndc_fda/nodes/60492-0173Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.